Evidence map›Paper›PMID 39021213›Full record

ArticleHaematologica2024

A targeted gene signature stratifying mediastinal gray zone lymphoma into classical Hodgkin lymphoma-like or primary mediastinal B-cell lymphoma-like subtypes.

Grazia Gargano, Maria Carmela Vegliante, Flavia Esposito, Susanna A Pappagallo, Elena Sabattini, Claudio Agostinelli, Stefano A Pileri, Valentina Tabanelli, Maurilio Ponzoni, Luisa Lorenzi and 22 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Grazia GarganoHematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy; Department of Mathematics, University of Bari Aldo Moro, Bari.
Maria Carmela VeglianteHematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari.
Flavia EspositoDepartment of Mathematics, University of Bari Aldo Moro, Bari.
Susanna A PappagalloHematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari.
Elena SabattiniHaematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna.
Claudio AgostinelliHaematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna.
Stefano A PileriDivision of Hematopathology, European Institute of Oncology IRCCS, Milan.
Valentina TabanelliDivision of Hematopathology, European Institute of Oncology IRCCS, Milan.
Maurilio PonzoniAteneo Vita-Salute San Raffaele Milan and Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan.
Luisa LorenziPathology Unit, Department of Molecular and Translational Medicine, University of Brescia, Brescia.
Fabio FacchettiPathology Unit, Department of Molecular and Translational Medicine, University of Brescia, Brescia.
Arianna Di NapoliDepartment of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Rome.
Marco LucioniDepartment of Molecular Medicine, University of Pavia/Foundation IRCCS Policlinico San Matteo, Pavia.
Marco PaulliDepartment of Molecular Medicine, University of Pavia/Foundation IRCCS Policlinico San Matteo, Pavia.
Lorenzo LeonciniSection of Pathology, Department of Medical Biotechnology, University of Siena, Siena.
Stefano LazziSection of Pathology, Department of Medical Biotechnology, University of Siena, Siena.
Stefano AscaniPathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, Terni.
Giuseppina OpintoClinical Pathology and Microbiology Unit, Bonomo Hospital, Andria (BT).
Gian Maria ZaccariaDepartment of Electrical and Information Engineering (DEI), Polytechnic University of Bari, Bari.
Giacomo VolpeHematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari.
Paolo MondelliHematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari.
Antonella BucciHematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari.
Laura SelicatoDepartment of Mathematics, University of Bari Aldo Moro, Bari.
Antonio NegriHematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari.
Giacomo LosetoHematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari.
Felice ClementeHematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari.
Anna ScattoneDepartment of Pathology, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari.
Alfredo F ZitoDepartment of Pathology, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari.
Luca NassiDepartment of Hematology, Careggi Hospital and University of Florence, Florence.
Nicoletta Del BuonoDepartment of Mathematics, University of Bari Aldo Moro, Bari.
Attilio GuariniHematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari.
Sabino CiavarellaHematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari. s.ciavarella@oncologico.bari.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39021213
PMCPMC11532716

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.